NO143663C - Analogifremgangsmaate for fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien - Google Patents

Analogifremgangsmaate for fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien

Info

Publication number
NO143663C
NO143663C NO4294/73A NO429473A NO143663C NO 143663 C NO143663 C NO 143663C NO 4294/73 A NO4294/73 A NO 4294/73A NO 429473 A NO429473 A NO 429473A NO 143663 C NO143663 C NO 143663C
Authority
NO
Norway
Prior art keywords
prostagland
preparing
series
connection
analogy procedure
Prior art date
Application number
NO4294/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO143663B (no
Inventor
Hans-Jurgen Ernst Hess
Thomas Ken Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to NO751878A priority Critical patent/NO751878L/no
Publication of NO143663B publication Critical patent/NO143663B/no
Publication of NO143663C publication Critical patent/NO143663C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO4294/73A 1972-11-08 1973-11-08 Analogifremgangsmaate for fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien NO143663C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO751878A NO751878L (ru) 1972-11-08 1975-05-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (2)

Publication Number Publication Date
NO143663B NO143663B (no) 1980-12-15
NO143663C true NO143663C (no) 1981-03-25

Family

ID=23177829

Family Applications (2)

Application Number Title Priority Date Filing Date
NO4294/73A NO143663C (no) 1972-11-08 1973-11-08 Analogifremgangsmaate for fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien
NO743616A NO144385C (no) 1972-11-08 1974-10-07 Mellomprodukt for fremstilling av nye pentanorprostaglandiner av e- eller f-serien

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO743616A NO144385C (no) 1972-11-08 1974-10-07 Mellomprodukt for fremstilling av nye pentanorprostaglandiner av e- eller f-serien

Country Status (20)

Country Link
JP (1) JPS5714347B2 (ru)
AT (1) AT345999B (ru)
BE (1) BE807046A (ru)
CA (1) CA1033727A (ru)
CH (1) CH593930A5 (ru)
DE (1) DE2355731C3 (ru)
DK (1) DK143499C (ru)
ES (3) ES420386A1 (ru)
FI (1) FI58912C (ru)
FR (3) FR2205338B1 (ru)
GB (1) GB1456838A (ru)
IE (1) IE40043B1 (ru)
IL (2) IL50310A (ru)
IN (1) IN139265B (ru)
NL (1) NL7315307A (ru)
NO (2) NO143663C (ru)
PH (2) PH13261A (ru)
SE (4) SE412229B (ru)
SU (2) SU667131A3 (ru)
ZA (1) ZA738595B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (de) * 1977-12-03 1979-06-07 Bayer Ag Neue bicycloalkenyl-prostaglandine und verfahren zu ihrer herstellung
TR200000671T2 (tr) * 1997-09-09 2000-07-21 The Procter & Gamble Company FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
SK3362000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound analogous to prostaglandin f and use thereof
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
DE502007000840D1 (de) * 2007-11-28 2009-07-16 Bauer Maschinen Gmbh Winde
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20230097470A1 (en) * 2021-08-23 2023-03-30 Chirogate International Inc. Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (ru) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
ES444398A1 (es) 1977-12-01
FR2205338B1 (ru) 1978-07-13
FI58912B (fi) 1981-01-30
FR2286147A1 (fr) 1976-04-23
FR2205338A1 (ru) 1974-05-31
CA1033727A (en) 1978-06-27
IN139265B (ru) 1976-05-29
AU6230273A (en) 1975-05-08
NO144385C (no) 1981-08-19
IE40043B1 (en) 1979-02-28
SE7612262L (sv) 1976-11-03
CH593930A5 (ru) 1977-12-30
IL43571A0 (en) 1974-03-14
DE2355731B2 (de) 1980-04-30
JPS49133357A (ru) 1974-12-21
PH13320A (en) 1980-03-13
SU667131A3 (ru) 1979-06-05
PH13261A (en) 1980-02-25
ES456279A1 (es) 1978-11-01
FR2286147B1 (ru) 1978-09-22
SE417957B (sv) 1981-04-27
IL50310A (en) 1977-08-31
BE807046A (fr) 1974-05-08
NO743616L (no) 1974-05-09
FR2291200B1 (ru) 1979-01-05
IL43571A (en) 1977-08-31
NO144385B (no) 1981-05-11
FR2291200A1 (fr) 1976-06-11
DK143499B (da) 1981-08-31
AT345999B (de) 1978-10-10
NO143663B (no) 1980-12-15
FI58912C (fi) 1981-05-11
DE2355731C3 (de) 1981-01-15
SE7612261L (sv) 1976-11-03
ES420386A1 (es) 1976-07-01
DK143499C (da) 1982-01-11
IE40043L (en) 1974-05-08
DE2355731A1 (de) 1974-05-22
ZA738595B (en) 1974-09-25
SE412229B (sv) 1980-02-25
SE7701523L (sv) 1977-02-10
SU704456A3 (ru) 1979-12-15
GB1456838A (en) 1976-11-24
NL7315307A (ru) 1974-05-10
ATA941073A (de) 1978-02-15
JPS5714347B2 (ru) 1982-03-24

Similar Documents

Publication Publication Date Title
NO139072C (no) Fremgangsmaate for fremstilling av et forprodukt for kjaeledyr
NO143663C (no) Analogifremgangsmaate for fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien
SE395366B (sv) Forfarande for framstellning av porosa tabletter
FI55807B (fi) Anordning foer applicering av klisterremsflikar
SE429100B (sv) Anordning for inforande av en kateter
SE404019B (sv) Forfarande for framstellnig av n-fosfonometylglycin
NO139689C (no) Fremgangsmaate for fremstilling av lateks
NO144223C (no) Fremgangsmaate til fremstilling av strekkbart papir
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE417968B (sv) Forfarande for framstellning av penamderivat
AR209426A1 (es) Procedimiento pra preparar compuestos de la serie de penicilina
SE448992B (sv) Forfarande for framstellning av en omega-pentanorprostaglandin ur e- eller f-serierna
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE413245B (sv) Forfarande for framstellning av optiskt aktiv (+)-lakton- eller -tiolakton-forening
NO144830C (no) Substituert cyklopentanderivat for anvendelse som mellomprodukt ved fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
FI55626C (fi) Anordning foer framstaellning av en behaollare
SE423092B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE415146B (sv) Forfarande for framstellning av forbettrad epoxideringskatalysator
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar